Brain accessibility delineates the central effects of circulating ghrelin. (12th February 2019)

• Record Type: Journal Article
• Authors: Perello, Mario; Cabral, Agustina; Cornejo, María P.; De Francesco, Pablo N.; Fernandez, Gimena; Uriarte, Maia
• Other Names: Abizaid Alfonso guestEditor.; Andrews Zane guestEditor.; Dickson Suzanne guestEditor.; Zigman Jeffrey guestEditor.
• Is Part Of: Journal of neuroendocrinology. Volume 31:Number 7(2019:Jul.)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-02-12
• Subjects: blood-brain-barrier -- blood-cerebrospinal fluid-barrier -- circumventricular organs -- ghrelin; Neuroendocrinology -- Periodicals; 616.4
• DOI: 10.1111/jne.12677
• Languages: English
• ISSNs: 0953-8194

Abstract

Abstract : Ghrelin is a hormone produced in the gastrointestinal tract that acts via the growth hormone secretagogue receptor. In the central nervous system, ghrelin signalling is able to recruit different neuronal targets that regulate the behavioural, neuroendocrine, metabolic and autonomic effects of the hormone. Notably, several studies using radioactive or fluorescent variants of ghrelin have found that the accessibility of circulating ghrelin into the mouse brain is both strikingly low and restricted to some specific brain areas. A variety of studies addressing central effects of systemically injected ghrelin in mice have also provided indirect evidence that the accessibility of plasma ghrelin into the brain is limited. Here, we review these previous observations and discuss the putative pathways that would allow plasma ghrelin to gain access into the brain together with their physiological implications. Additionally, we discuss some potential features regarding the accessibility of plasma ghrelin into the human brain based on the observations reported by studies that investigate the consequences of ghrelin administration to humans.